Mometasonfuroaat Teva (Mometasone Furoate)

Mometasone furoate binds to glucocorticoid receptors inside skin cells, altering gene transcription. This suppresses the production of inflammatory cytokines, chemokines and other mediators while enhancing anti‑inflammatory proteins, leading to decreased cellular infiltration, edema and the clinical signs of skin inflammation.

The specific dosing regimen is determined by the prescribing clinician based on the severity of the condition, the area of skin involved and patient age. Typically, a thin layer is applied once or twice daily to the affected area, but exact frequency and duration must follow the prescriber’s instructions.

Safety data for mometasone furoate in pregnancy and lactation are limited. The product should only be used if the potential benefit justifies any potential risk to the fetus or infant. Women who are pregnant, planning pregnancy, or breastfeeding should discuss use with their healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Mometasone furoate is considered a high‑potency topical steroid, offering strong anti‑inflammatory effects with once‑daily application. Compared with lower‑potency agents such as hydrocortisone, it provides faster symptom control but carries a higher risk of local side effects if used excessively. It is less potent than super‑high‑potency steroids like clobetasol, offering a balance between efficacy and safety for many dermatologic indications.

Store the product at room temperature, preferably below 25 °C, in its original packaging. Protect it from excessive moisture, heat and direct sunlight. Keep the container tightly closed when not in use and out of reach of children.

The medication is applied topically to clean, dry skin. A thin film should be spread over the affected area, gently massaged in until absorbed. Avoid contact with eyes, mucous membranes and broken skin unless directed by a healthcare professional.

Serious risks include skin atrophy, hypopigmentation, secondary infections (bacterial, fungal or viral), systemic absorption leading to adrenal suppression, and rare allergic reactions such as angioedema. Patients should report any unusual skin changes, severe irritation or systemic symptoms to their clinician promptly.

The product should be avoided in individuals with known hypersensitivity to mometasone furoate or any formulation excipients. It is also contraindicated on skin infected with bacterial, fungal or viral agents unless combined with appropriate antimicrobial therapy, and should not be used on large surface areas or under occlusion without medical supervision.